SAR441566
SAR441566 is a pharmaceutical drug with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis
A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.
Clinical Trials (7)
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis
A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.
A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566
A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7